SCHEMBL23224727

SCHEMBL23224727

C=CN(CC)CCCCNc1ncc2cc(-c3cc(OC)cc(OC)c3)c(NC(=O)NC(C)(C)C)nc2n1

nearest known ligand 0.83

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 20/20 0.83
FGFR2 P21802 16/20 0.83
FGFR4 P22455 16/20 0.83
FGFR3 P22607 16/20 0.83
FLT1 P17948 11/20 0.83
FLT4 P35916 11/20 0.83
KDR P35968 11/20 0.83
SRC P12931 3/20 0.83
GLA P06280 1/20 0.83
CSK P41240 1/20 0.83
KMT2A Q03164 1/20 0.83
ATM Q13315 1/20 0.83
EGFR P00533 3/20 0.58
PRKD3 O94806 1/20 0.58
PRKCG P05129 1/20 0.58
PRKCB P05771 1/20 0.58
PRKCA P17252 1/20 0.58
PRKCH P24723 1/20 0.58
PRKCI P41743 1/20 0.58
PRKCE Q02156 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pd-173074 SCHEMBL29828472 0.91 FGFR1 (1.00) FGFR1FGFR2FGFR4FGFR3FLT1
Pd-173074 SCHEMBL177946 0.91 FGFR1 (1.00) FGFR1FGFR2FGFR4FGFR3FLT1
SCHEMBL3479994 0.90 FGFR1 (0.87) FGFR1FGFR2FGFR4FGFR3FLT1
SCHEMBL22144559 0.88 FGFR1 (0.95) FGFR1FGFR2FGFR4FGFR3FLT1
SCHEMBL2470675 0.86 FGFR1 (0.85) FGFR1FGFR2FGFR4FGFR3FLT1
SCHEMBL16489372 0.86 FGFR1 (0.91) FGFR1FGFR2FGFR4FGFR3FLT1
SCHEMBL17814860 0.86 FGFR1 (0.90) FGFR1FGFR2FGFR4FGFR3FLT1
SCHEMBL5619204 0.86 FGFR1 (0.84) FGFR1FGFR2FGFR4FGFR3FLT1
SCHEMBL30737861 0.85 FGFR1 (1.00) FGFR1FGFR2FGFR4FGFR3FLT1
SCHEMBL19848922 0.85 FGFR1 (0.80) FGFR1FGFR2FGFR4FGFR3FLT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021072319-A1 TARGETED TREATMENT OF CANCERS WITH DYSREGULATED FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING G1 THERAPEUTICS, INC. (US) 2021-04-15 WO disclosed